Recent advances in SPECT technology including cadmium zinc telluride (CZT) semi-conductor detector material may pave the way for absolute myocardial blood flow (MBF) measurements by SPECT. The aim of the present study was to compare K1 uptake rate constants as surrogates of absolute MBF and myocardial flow reserve index (MFRi) in humans as assessed with a CZT SPECT camera versus positron emission tomography (PET).
INTRODUCTION
The definition of coronary artery disease (CAD) was originally based on the presence of anatomic luminal narrowing greater than 50%. Over the past decades, however, many advances in imaging techniques have enhanced our pathophysiologic understanding of CAD. It has been recognized that many factors beyond luminal narrowing may determine whether or not an anatomical coronary lesion induces ischemia. As this cannot be comprehensively addressed by coronary angiography alone, nuclear myocardial perfusion imaging (MPI) has been well established as a tool for providing proof of ischemia. This is mandatory for prognostically relevant target lesion revascularization in chronic stable CAD. As revascularization of a non-flow limiting coronary stenosis is not beneficial to the patient, neither from a prognostic nor from a symptomatic point of view nuclear MPI has been suggested as a gatekeeper for invasive coronary angiography (1) (2) (3) . MPI studies with positron emission tomography (PET) have demonstrated that absolute myocardial blood flow (MBF) and flow reserve (MFR) provide incremental diagnostic (4) and prognostic (5) information over relative perfusion alone.
Quantitative assessment of MBF is difficult with standard SPECT where detectors need to rotate around the patient and where unfavorable properties of the currently available flow tracers hamper accurate MBF quantification due to non-linear extraction fraction with roll-off at higher flow values. The recent advances in SPECT technology including semi-conductor detector material (cadmium zinc telluride; CZT) allow acquisition in a non-rotating mode and therefore acquisition of time-activity curves. This may enable absolute MBF and MFR estimation by single photon computed tomography (SPECT) as recently shown in experimental animal models (6) which may pave the way for its implementation in clinical routine (7) . More knowledge on the impact of the tracer properties on the values obtained from quantification is crucial.
by on October 14, 2017. For personal use only. jnm.snmjournals.org Downloaded from
The aim of the present study was a head-to-head comparison in humans of indexes of absolute MBF and MFR as assessed with 99mTc-tetrofosmin on a CZT SPECT camera versus MBF and MFR measured with 13N-ammonia on a PET scanner.
MATERIALS AND METHODS

Patient Population
Thirty-two consecutive patients referred to nuclear MPI with either CZT SPECT or PET for clinical evaluation were enrolled. For study purposes the patients underwent a second MPI with the respective other modality to obtain a pair of SPECT and PET MPI for each patient. In patients without any therapeutic intervention (i.e. no revascularization and no change in medication) a time interval of 2 weeks was accepted. In patients with no therapeutic intervention and chronic stable conditions a maximal time interval of 12 weeks was accepted. The sequence was SPECT first in 25 and PET first in 7 patients. The local ethics committee approved this study and all subjects signed a written informed consent.
13N-Ammonia PET
The PET MPI scan was acquired during pharmacologic stress with an adenosine protocol at a standard rate (0.14 mg/kg/min) over 6 minutes and at rest according to clinical standards (4, 8) . For the stress acquisition 13N-ammonia (1053 ± 110 MBq) was injected 3 minutes into pharmacologic stress into a peripheral vein. Acquisition was repeated at rest (1203 ± 148 MBq) 50 minutes after completion of the stress scan to allow for isotope decay. Images were acquired during 19 minutes in list-mode on a PET/CT scanner (Discovery ST/RX and Discovery VCT, both GE Healthcare, Milwaukee, WI, USA). Images were reconstructed using a matrix of 128*128 and filtered back projection into dynamic series encompassing the first 4 minutes (9x 10-s, 6x 15-s, 3x 20-s) for absolute MBF quantification and into a static series (15 remaining minutes) for assessment of relative perfusion abnormalities. A low-dose CT transmission scan was used for attenuation correction (9).
99mTc-Tetrofosmin CZT SPECT
The CZT MPI scan was acquired on a hybrid SPECT/CT scanner (DNM 570c; GE Healthcare, Milwaukee, WI, USA) using the 1-d stress/rest protocol identical to the described protocol above. The SPECT part is a gamma camera with multi-pinhole collimation and 19 non rotating pixelated CZT detector modules positioned around the patient`s chest with full heart coverage (10). Due care was taken to assure that patients were positioned in the middle of the field of view and this was confirmed for each patient after the scan. A low dose CT attenuation scan was acquired using the CT component of the same scanner (11) . For the stress acquisition 99mTc-tetrofosmin (330±33 MBq) was injected 3 minutes into pharmacologic stress into a peripheral vein. Images were acquired in list-mode over 10 minutes starting immediately (a few seconds) before tracer injection. Five minutes after completion of the first scan a second tracer injection with 3 fold higher dose was administrated according to current guidelines and the same acquisition protocol was applied (8) . For logistic reasons, in 5 patients a rest/stress sequence was used for CZT scanning. Dynamic series including the first 4 minutes (6 x 10s, 6 x 30s) were generated using a dedicated commercially available software package (Myovation for Alcyone; GE Healthcare, Milwaukee, WI, USA) and reconstructed after attenuation correction using a maximum penalized likelihood iterative reconstruction (40 and 50 iterations applied for the stress and rest dataset, respectively) without scatter correction. A Butterworth post processing filter with cut-off frequency 0.37 cycle/cm and order 7 was equally applied (10).
Absolute Myocardial Blood Flow Quantification
The MBF values for 13N-ammonia PET (PET MBF) as well as the MBFi values for 99mTc-tetrofosmin CZT SPECT (CZT MBFi) were estimated using the commercially available PMOD software package (version 3.1, PMOD Technologies Ltd, Zurich, Switzerland) developed and validated at our institution (12, 13) . Regions of interest in the right ventricle cavity, left ventricle cavity, and covering the left ventricular myocardium were automatically generated and minimally modified as necessary by an experienced reader to best match cardiac anatomy and by on October 14, 2017. For personal use only. jnm.snmjournals.org Downloaded from avoid contamination from extracardiac activity. A one-tissue compartment model described by De Grado et al. was used for tracer kinetic modelling inferring a myocardium tissue density of 1.04 g/ml (14, 15) . Global MBF values were determined after fitting the tissue activity curves of the myocardial as well as right ventricular and left ventricular values (16) . No specific correction of the quantification process was performed despite the higher residual activity during the second half of CZT study. Furthermore, no correction of the quantification model was applied despite differences in the extraction fraction and metabolites present for 99mTc-tetrofosmin compared to ammonia. Therefore, the MBF values obtained during the CZT study are rather indexes of the flow (MBFi) at rest and stress and their stress/rest ratio is the MFR index (MFRi).
An image illustration during dynamic acquisition with CZT is displayed in Figure 1 
Statistical Analysis
The continuous values were summarized as mean ± standard deviation and parametric values as percentage or median and interquartile range as appropriate. Shapiro Wilk test was used to test for normal distribution. Results from both MPI methods were compared using Wilcoxon signed rank test and spearman correlation coefficient was calculated. A receiver by on October 14, 2017. For personal use only. jnm.snmjournals.org Downloaded from operator characteristics (ROC) analysis was conducted to evaluate the diagnostic accuracy of CZT in the detection of patients with MFR < 2 by PET. All P values < 0.05 were considered statistically significant. SPSS 22.0 (SPSS, Chicago, IL, USA) was used for the statistical analysis.
RESULTS
Four patients were excluded from further analysis according to predefined quality criteria for quantitative PET. The final study population consisted of 28 patients (86% males) with a mean age of 64 ± 10 years and a BMI of 28 ± 6 kg/m 2 ( Table 1) . Kinetic modeling curves and polar maps at rest and stress for a representative patient are displayed using PET ( Figure 3 The ROC revealed a cut-off for CZT MFRi at 1.26 to predict an abnormal PET MFR.
Using the latter cut-off value, CZT correctly identified 14/18 patients (specificity:
MFR ≥ 2 and 7/10 (sensitivity: 70%) with PET MFR < 2, yielding an accuracy of 75% ( Figure 6 ).
The MBF values at rest and stress in patients with correctly identified and misidentified PET MFR when using CZT is displayed in Table 2 .
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DISCUSSION
Our study is the first to compare in humans MBF data from dynamic CZT acquisition with data from PET, which is considered the gold standard for quantitative non-invasive MBF assessment (17) . Our results demonstrate that quantification of dynamic SPECT MPI on modern CZT cameras is technically feasible but without specific correction for the different extraction Despite the limited size of the study the strength of these results lies in the fact that each patient served as their own internal control and the cut-off for abnormal perfusion detection was a PET MFR < 2, which is a robust and widely accepted threshold both for diagnostic (4) and prognostic CAD assessment (5,31). 99mTc-tetrofosmin was used in this study because it constitutes the most commonly used radiotracer used for SPECT MPI in daily clinical routine. However 99mTc-tracers with more favorable tracer kinetics such as found for teboroxime (32) 
anatomic reference would represent a flawed gold standard for quantitative MBF measurements and would require assessment of invasive fractional flow reserve (FFR), which is not feasible for ethical reasons due to its invasive nature in patients with normal findings. Furthermore, we have confined our study to global rather than regional values which may potentially constitute a limitation. However, global MFR reflects CAD beyond the epicardial section of the coronary tree involving microcirculation, including endothelial dysfunction, which has been shown to increase the sensitivity in detecting CAD when global MFR is used as an adjunct to PET MPI. The use of global MFR appears to be most appropriate when the aspect of microcirculatory dysfunction is included, which is often associates with CAD. Furthermore, for reasons of feasibility implementation of global MFR seems preferable over regional MFR because the reproducibility and the repeatability of global MFR is considerably superior to that of regional MFR from PET (13, 33) . This may apply even more for SPECT measurements due to technical issues and count statistics including lower spatial resolution which may affect the apparent perfusion values in a non-homogenous manner, leading to different patterns in the polar plots for PET and SPECT as depicted in Figures 3 and 4 . It is also based on biologic variability, as a profound spatial heterogeneity has been observed in regional MBF at rest and in response to vasodilator stress (34, 35) . The anatomic variability of the coronary trees is another source which has been shown to affect the per-segment performance of quantitative MBF measurements. Finally, our study has been performed using an integrated SPECT-CT but without scatter correction and therefore extrapolation to protocols with separate acquisition on standalone CT and CZT SPECT scanners and to protocols using scatter correction should be done with caution. 
